Top 10 New Entrants companies in Prostate cancer by Most Patent Filing In 3 Years in the South Korea in 2018 – Discovery

Free Trial

The Prostate cancer top 10 is Discovery PatSnap’ annual ranking of the top 10 Most Patent Filing In 3 Years Prostate cancer New Entrants in the South Korea. Discovery has identified the top key players, startups & unicorns, fast-growings, news entrants in 2018, ranking from differnt perspectives, including patent filing intensity, academic research capability, news media heat. The company list is generated from various data types.

Ranking Year:

Region:

Ranking:

1	FutureChem Co., Ltd.	Gyeonggi-do, South Korea	MRI contrast agent,Microbubbles,Bioconjugation, ...[+2]	Patent: 15
2	Incheon University Industry Academic Cooperation Foundation	South Korea		Patent: 12
3	Samjin Pharmaceutical Co., Ltd.	South Korea	Immunotherapy,Medicine,Root cause, ...[+2]	Patent: 10
4	CellBion Co., Ltd.	Seoul, South Korea	Drug,Medicine	Patent: 8
5	Gachon University of Industry-Academic Cooperation Foundation	South Korea		Patent: 8
6	Moogene Medi Co., Ltd.	Gyeonggi-do, South Korea	Nanotechnology,Nanomaterials	Patent: 5
7	KOREA UNITED PHARM, Inc.	South Korea	Pharmaceutical drug,Medicine,Health care	Patent: 4
8	Research & Business Foundation Sungkyunkwan University	South Korea		Patent: 2
9	J Chem Corp.	South Korea		Patent: 2
10	STARTUP Deepbio Co. Ltd.	South Korea	Digital pathology,Medical diagnosis,Health care, ...[+2]	Patent: 2